FMR1 and fragile X syndrome: Inhibition of <i>FMR1</i>-SFs with shRNAs or small molecules reactivates <i>FMR1</i> in cultured undifferentiated induced pluripotent stem cells, neural progenitor cells (NPCs) and post-mitotic neurons derived from FXS patients.